Streetbeat News

Price Targets

IAS

Morgan Stanley analyst Brian Nowak has maintained an Overweight rating on Integral Ad Science (NASDAQ:IAS) but lowered the price target from $21.5 to $16.5.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 12:56 pm

FTNT

Morgan Stanley analyst Hamza Fodderwala has maintained an Overweight rating on Fortinet (NASDAQ:FTNT) but lowered the price target from $75 to $60.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 12:54 pm

RACE

Morgan Stanley analyst Adam Jonas has maintained an Overweight rating on Ferrari (NYSE:RACE) and raised the price target from $340 to $350.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 12:53 pm

CMA

Wedbush analyst David Chiaverini has downgraded Comerica (NYSE:CMA) from Outperform to Neutral and lowered the price target from $47 to $45.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 12:52 pm

ETSY

Morgan Stanley analyst Lauren Schenk has maintained an Equal-Weight rating on Etsy (NASDAQ:ETSY) and lowered the price target from $72 to $66.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 12:52 pm

LLY

Morgan Stanley analyst David Phung has maintained an Overweight rating on Eli Lilly (NYSE:LLY) and raised the price target from $673 to $722.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 12:50 pm

XRAY

Morgan Stanley analyst Erin Wright has maintained an Overweight rating on Dentsply Sirona (NASDAQ:XRAY) but lowered the price target from $43 to $39.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 12:49 pm

DH

Morgan Stanley analyst Craig Hettenbach has maintained an Overweight rating on Definitive Healthcare (NASDAQ:DH), but lowered the price target from $15.5 to $9.5.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 12:48 pm

CYBR

Morgan Stanley analyst Hamza Fodderwala maintains an Overweight rating on CyberArk Software (NASDAQ:CYBR) and raises the price target from $180 to $195.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 12:47 pm

CRTO

Morgan Stanley analyst Brian Nowak has maintained an Equal-Weight rating on Criteo (NASDAQ:CRTO) and lowered the price target from $38 to $22.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 12:46 pm